Trial intelligence / Profile preview

Azithromycin for Asthma and COPD Exacerbations

NCT00181272Phase 2Terminated

Sponsor
Johns Hopkins University
Start
Sep 2005
Primary completion
Jul 2006
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of azithromycin in asthma, chronic obstructive pulmonary disease (COPD), sponsored by Johns Hopkins University. Started Sep 2005; status: terminated.

02

Drugs

azithromycin
03

Conditions

asthmachronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on NCT00181272.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00181272.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call